Stockscreener 앱 받기
0.63%
시간 외 거래:
전일 마감가:
$23.90
열려 있는:
$23.98
하루 거래량:
46.29M
Relative Volume:
1.12
시가총액:
$136.74B
수익:
$63.83B
순이익/손실:
$10.77B
주가수익비율:
12.79
EPS:
1.88
순현금흐름:
$12.44B
1주 성능:
-2.12%
1개월 성능:
-4.34%
6개월 성능:
-7.68%
1년 성능:
-19.38%
1일 변동 폭
$23.90
$24.39
1주일 범위
$23.68
$24.86
52주 변동 폭
$20.91
$30.43
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
24.05 | 135.88B | 63.83B | 10.77B | 12.44B | 1.88 |
|
LLY
Lilly Eli Co
|
760.13 | 685.53B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
177.20 | 424.98B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
220.81 | 382.04B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
122.47 | 237.68B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
81.14 | 202.55B | 63.43B | 16.42B | 14.72B | 6.49 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Canandaigua National Bank & Trust Co. Boosts Holdings in Pfizer Inc. $PFE - MarketBeat
Quintet Private Bank Europe S.A. Buys 108,608 Shares of Pfizer Inc. $PFE - MarketBeat
Canandaigua National Trust Co of Florida Boosts Holdings in Pfizer Inc. $PFE - MarketBeat
Bourne Lent Asset Management Inc. Purchases 18,200 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Teamwork Financial Advisors LLC - MarketBeat
Modern Wealth Management LLC Purchases 13,104 Shares of Pfizer Inc. $PFE - MarketBeat
Wesbanco Bank Inc. Has $5.19 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Wealth Alliance Advisory Group LLC Reduces Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Arvest Investments Inc. - MarketBeat
Jones Financial Companies Lllp Buys 690,259 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Stock Holdings Lowered by Jacobs & Co. CA - MarketBeat
Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party - 104.1 WIKY
Arvinas (ARVN) and Pfizer Shift Commercialization Strategy for Cancer Drug - GuruFocus
Pfizer (PFE) and Arvinas Seek Partner for Vepdegestrant's Commer - GuruFocus
Pfizer Inc. $PFE Shares Sold by Swedbank AB - MarketBeat
Pfizer Inc. $PFE Holdings Decreased by Neville Rodie & Shaw Inc. - MarketBeat
Voya Investment Management LLC Increases Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Invst LLC - MarketBeat
Arvinas and Pfizer to out-license breast cancer drug vepdegestrant - Investing.com
Arvinas, Pfizer to outlicense commercialization of cancer asset vepdegestrant - Seeking Alpha
Arvinas and Pfizer Announce Out-Licensing Strategy for Vepdegestrant and Cost Optimization Initiatives - Quiver Quantitative
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation - GlobeNewswire
$100M Cost Savings: Arvinas Restructures, Out-Licenses Cancer Drug & Launches Major Share Buyback - Stock Titan
Pfizer: Cheap Doesn't Mean Good (NYSE:PFE) - Seeking Alpha
Roivant and Pfizer-backed Priovant post late-stage trial win for dermatomyositis therapy - Seeking Alpha
PFIZER INC : Berenberg reiterates its Neutral rating - MarketScreener
Assessing Pfizer Shares After Trump Officials Link COVID Vaccines to Child Deaths - Yahoo Finance
Pfizer Inc. $PFE Shares Sold by Sarasin & Partners LLP - MarketBeat
InvesTrust Has $1.81 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Adams Asset Advisors LLC Has $7.17 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Acquired by Sunpointe LLC - MarketBeat
Intech Investment Management LLC Has $7.62 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Mirador Capital Partners LP Buys 11,662 Shares of Pfizer Inc. $PFE - MarketBeat
Gateway Investment Advisers LLC Buys 66,491 Shares of Pfizer Inc. $PFE - MarketBeat
Westbourne Investments Inc. Cuts Position in Pfizer Inc. $PFE - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Has $10.36 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Bought by Krilogy Financial LLC - MarketBeat
Fiduciary Alliance LLC Acquires 89,635 Shares of Pfizer Inc. $PFE - MarketBeat
NBC Securities Inc. Decreases Stock Holdings in Pfizer Inc. $PFE - MarketBeat
First Financial Bank Trust Division Sells 20,173 Shares of Pfizer Inc. $PFE - MarketBeat
AG2R LA Mondiale Gestion D Actifs Invests $4.95 Million in Pfizer Inc. $PFE - MarketBeat
Rep. Lisa C. McClain Sells Pfizer Inc. (NYSE:PFE) Stock - MarketBeat
Oncology One, Pfizer, WEHI, Cancer Therapeutics CRC and partners advance Australian-discovered KAT6 inhibitor into Phase 3 breast cancer trial - BioMelbourne Network
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.26%
자본화:
|
볼륨(24시간):